• DDI2-NFE2L1-Proteasome Axis Protects Against Ferroptosis

  2026-07-14

  This study uncovers how activation of the NFE2L1-ubiquitin-proteasome system by DDI2 defends cells from ferroptosis. By dissecting the molecular feedback between proteasomal activity and lipid peroxidation, the research highlights new therapeutic targets for diseases involving regulated cell death and protein homeostasis.

• Mc-Val-Cit-PABC-PNP: Technical Guidance for ADC Synthesis

  2026-07-14

  Mc-Val-Cit-PABC-PNP is a cathepsin-cleavable ADC peptide linker designed for selective lysosomal payload release in antibody-drug conjugate (ADC) research workflows. It is optimal for organic solvent-based protocols but unsuitable for water-based, diagnostic, or clinical applications. Researchers benefit from its stability and cleavage specificity when precise intracellular drug delivery is required.

• Antiarrhythmic Agents and KCa2 Channel Modulation in AF Rese

  2026-07-13

  The referenced study systematically evaluated the effects of clinically recommended antiarrhythmic drugs—including dronedarone (Multaq)—on small conductance calcium-activated potassium (KCa2.X) channels, a promising atrial-selective target in atrial fibrillation research. The findings reveal that, at therapeutic concentrations, most standard agents do not meaningfully inhibit these channels, highlighting a critical gap and future research direction for atrial fibrillation pharmacology.

• Bradford Protein Assay Kit: Rapid, Sensitive Quantification

  2026-07-13

  The Bradford Protein Assay Kit addresses the need for rapid, sensitive, and accurate protein concentration measurement in biochemical research. It is optimal for workflows requiring low sample volumes and high throughput, but is not recommended for samples with high detergent content or when absolute quantitation across diverse protein classes is required.

• Rhodamine B (SKU A4705): Reliable Fluorescent Probe for Cell

  2026-07-12

  This article provides a scenario-driven, evidence-based guide to using Rhodamine B (SKU A4705) as a fluorescent probe in cell viability, proliferation, and cytotoxicity workflows. Drawing from real laboratory challenges, peer-reviewed data, and APExBIO’s product dossier, we illustrate how Rhodamine B enhances assay reproducibility, sensitivity, and workflow flexibility for biomedical researchers and technicians.

• Purmorphamine: Unlocking Osteogenic and Sensory Pathways via

  2026-07-10

  Explore how Purmorphamine, a potent Smoothened agonist, advances bone regeneration and sensory research through precise Hedgehog pathway modulation. This article offers advanced scientific insights and fresh assay perspectives not found in existing content.

• Regorafenib (BAY 73-4506): Mechanistic Frontiers in Translat

  2026-07-09

  This thought-leadership article examines Regorafenib (BAY 73-4506) as a pioneering tool for translational oncology research. It integrates mechanistic insights—such as RRM2 and ERK/E2F3 pathway modulation in melanoma—with strategic guidance for designing advanced experimental workflows. By synthesizing recent evidence and highlighting practical protocols, the article offers researchers a roadmap to leverage Regorafenib in angiogenesis, tumor xenograft models, and metastasis research, while distinguishing itself from conventional product content.

• PLK1 Regulation of p31comet Controls Mitotic Checkpoint Disa

  2026-07-09

  This study establishes that Polo-like kinase 1 (PLK1) directly phosphorylates p31comet, inhibiting its ability to disassemble mitotic checkpoint complexes (MCC) in coordination with TRIP13. These findings clarify a negative regulatory mechanism tuning cell cycle progression and have significant implications for cancer research targeting PLK1-mediated pathways.

• Proteinase K: Broad-Spectrum Serine Protease for DNA Integri

  2026-07-08

  Proteinase K is a broad-spectrum serine protease crucial for high-fidelity protein hydrolysis and contaminant removal during genomic DNA isolation. Its robust activity profile, resistance to common inhibitors, and compatibility with diverse experimental conditions make it an industry gold standard for DNA integrity preservation in molecular biology workflows.

• Pyridostatin TFA: Enabling Precision in G-Quadruplex Targeti

  2026-07-08

  Explore how Pyridostatin TFA, a selective G-quadruplex stabilizer, advances DNA secondary structure research and anticancer drug development. This article uniquely connects protocol optimization and mechanistic insights from recent neurodegeneration studies.

• Dissecting Fruit Abscission in Actinidia arguta via Transcri

  2026-07-07

  Yuan et al. used comparative transcriptomics and transient genetic transformation to clarify the molecular networks governing fruit abscission in Actinidia arguta. Their findings highlight key hormone signaling and cell wall modification genes, advancing strategies for mitigating early fruit drop in commercial cultivars.

• 5-(N,N-dimethyl)-Amiloride Hydrochloride in Endothelial Ion

  2026-07-07

  Explore how 5-(N,N-dimethyl)-Amiloride hydrochloride empowers advanced research on ion transport and intracellular pH regulation in endothelial injury and sepsis models. This article uniquely integrates mechanistic insights and translational protocol guidance.

• DAT Neuroimaging Reveals Dopaminergic Maturation in PD Model

  2026-07-06

  Goggi et al. (2020) demonstrate that dopamine transporter (DAT) neuroimaging provides a robust, non-invasive method for tracking the maturation and functional integration of transplanted human embryonic stem cell-derived dopaminergic neurons in a preclinical Parkinson’s disease model. Their approach enables longitudinal assessment of cell therapy outcomes and highlights the importance of in vivo imaging for advancing regenerative strategies in neurodegenerative disease.

• Targeting the CaN/FoxO1/FABP4 Axis to Prevent Foam Cell Form

  2026-07-06

  This study uncovers how SERCA2 dysfunction accelerates atherosclerosis by activating the calcineurin/FoxO1/FABP4 pathway, promoting macrophage foam cell formation. Targeted inhibition of FABP4 or FoxO1 was shown to restore lipid metabolism and reduce lesion development, highlighting a mechanistically precise therapeutic strategy for cardiovascular disease research.

• KR-12: Translational Leverage for Narrow-Spectrum Antimicrob

  2026-07-05

  This thought-leadership article dissects the mechanistic underpinnings and strategic translational value of KR-12, the minimal human antimicrobial peptide fragment of LL-37, emphasizing structure-function insights, practical workflow design, and future positioning in the competitive antimicrobial and immunomodulation research landscape. Drawing from foundational structural biology, peer-reviewed evidence, and advanced experimental protocols, this piece delivers actionable guidance for researchers aiming to bridge preclinical discovery with therapeutic application.

460 records 12/31 page Previous Next First page 上5页 1112131415 下5页 Last page